Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (12 quarters reported)
$375M in Q4 2023 → $560M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| SR Scholar Rock Hldg Corp | 5.9% | Added 188% | 688,954 | $33.3M |
| Erasca Inc | 5.9% | Added 44% | 2,260,594 | $33.1M |
| AS Abivax Sa | 4.9% | Trimmed 1.5% | 279,398 | $27.7M |
| Tango Therapeutics Inc | 4.4% | Trimmed 19% | 989,345 | $24.7M |
| Roivant Sciences Ltd | 4.2% | Added 84% | 641,473 | $23.5M |
| First Tracks Biotherapeutics | 4.1% | Added 4.4% | 649,924 | $23M |
| Enliven Therapeutics Inc | 2.7% | Trimmed 4.7% | 330,476 | $15.1M |
| Alkermes PLC | 2.4% | Added 34% | 333,332 | $13.5M |
| AB Adaptive Biotechnologies Cor | 2.4% | New | 463,551 | $13.4M |
| Dianthus Therapeutics Inc | 2.4% | Trimmed 25% | 150,776 | $13.3M |
| Faeth Therapeutics Inc | 2.2% | New | 404,921 | $12M |
| Spyre Therapeutics Inc | 2.1% | Added 24% | 132,238 | $11.8M |
| IN Immatics N.v | 2.1% | New | 1,308,193 | $11.5M |
| Grail Inc | 2.1% | New | 81,924 | $11.5M |
| PP Praxis Precision Medicines I | 2.0% | Added 4.0% | 38,720 | $11.3M |
| Surrozen Inc | 2.0% | Trimmed 31% | 418,527 | $11.1M |
| C4 Therapeutics Inc | 2.0% | Added 529% | 3,293,376 | $11M |
| Aclaris Therapeutics Inc | 1.9% | New | 2,050,698 | $10.8M |
| Damora Therapeutics Inc | 1.9% | New | 506,067 | $10.8M |
| Revolution Medicines Inc | 1.8% | Trimmed 69% | 50,000 | $10.3M |
| Cytokinetics Inc | 1.7% | Added 93% | 145,760 | $9.61M |
| Beone Medicines Ltd | 1.6% | New | 25,051 | $9.17M |
| Xenon Pharmaceuticals Inc | 1.5% | Added 192% | 222,287 | $8.27M |
| Johnson & Johnson | 1.4% | New | 30,000 | $7.94M |
| Trevi Therapeutics Inc | 1.4% | New | 552,245 | $7.91M |
| Eli Lilly & Co | 1.4% | New | 6,599 | $7.64M |
| AP Arrowhead Pharmaceuticals In | 1.3% | Added 180% | 109,926 | $7.19M |
| Cerus Corp | 1.3% | New | 2,967,942 | $7.06M |
| Immunovant Inc | 1.2% | Trimmed 27% | 201,334 | $6.8M |
| Jade Biosciences Inc | 1.2% | New | 471,718 | $6.63M |
| Guardant Health Inc | 1.1% | New | 33,527 | $5.98M |
| Omniab Inc | 1.1% | New | 1,204,038 | $5.97M |
| Cogent Biosciences Inc | 1.1% | New | 184,173 | $5.9M |
| Biohaven Ltd | 0.9% | Trimmed 63% | 396,865 | $5.3M |
| Mineralys Therapeutics Inc | 0.9% | Trimmed 67% | 200,000 | $5.03M |
| Ideaya Biosciences Inc | 0.8% | New | 123,760 | $4.75M |
| Celcuity Inc | 0.8% | Trimmed 41% | 57,880 | $4.6M |
| Gh Research PLC | 0.8% | New | 195,143 | $4.58M |
| Edgewise Therapeutics Inc | 0.8% | New | 111,577 | $4.53M |
| IN Inflarx Nv | 0.8% | Trimmed 23% | 2,485,233 | $4.47M |
| Century Therapeutics Inc | 0.8% | Added 19% | 2,563,862 | $4.38M |
| Biodesix Inc | 0.8% | Added 102% | 141,548 | $4.22M |
| Biontech Se | 0.7% | New | 42,200 | $4.15M |
| SS Sanofi Sa | 0.7% | New | 99,880 | $4.12M |
| Aura Biosciences Inc | 0.7% | Trimmed 9.4% | 647,406 | $4.07M |
| Cg Oncology Inc | 0.7% | Trimmed 66% | 54,791 | $3.88M |
| NP Newamsterdam Pharma Company | 0.7% | Added 105% | 159,044 | $3.87M |
| KP Kiniksa Pharmaceuticals Intl | 0.7% | Trimmed 75% | 51,804 | $3.87M |
| VT Viridian Therapeutics Inc | 0.7% | New | 187,320 | $3.86M |
| Vor Biopharma Inc | 0.7% | New | 200,836 | $3.83M |
| Lb Pharmaceuticals Inc | 0.6% | Added 189% | 91,757 | $3.47M |
| Edesa Biotech Inc | 0.6% | New | 825,000 | $3.47M |
| AP Avalyn Pharmaceuticals Inc | 0.6% | Unchanged | 118,000 | $3.36M |
| Intuitive Surgical Inc | 0.6% | New | 8,087 | $3.29M |
| Nurix Therapeutics Inc | 0.6% | New | 137,973 | $3.27M |
| Ovid Therapeutics Inc | 0.6% | Trimmed 47% | 1,287,804 | $3.21M |
| Cue Biopharma Inc | 0.5% | Added 62% | 108,647 | $2.81M |
| UT United Therapeutics Corp Del | 0.4% | New | 4,646 | $2.52M |
| Dyne Therapeutics Inc | 0.4% | New | 154,234 | $2.48M |
| AT Attovia Therapeutics Inc | 0.4% | New | 138,200 | $2.37M |
Showing top 60 of 91 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed November 16, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Revolution Medicines Inc | Trimmed | −109,943 | −$22.6M | 1.8% |
| SR Scholar Rock Hldg Corp | Added | +449,808 | +$21.7M | 5.9% |
| Tyra Biosciences Inc | Exited | −632,754 | −$20.2M | — |
| AB Adaptive Biotechnologies Cor | New | +463,551 | +$13.4M | 2.4% |
| Faeth Therapeutics Inc | New | +404,921 | +$12M | 2.2% |
| KP Kiniksa Pharmaceuticals Intl | Trimmed | −157,430 | −$11.7M | 0.7% |
| IN Immatics N.v | New | +1,308,193 | +$11.5M | 2.1% |
| Grail Inc | New | +81,924 | +$11.5M | 2.1% |
| Bioage Labs Inc | Exited | −464,171 | −$11.4M | — |
| Aclaris Therapeutics Inc | New | +2,050,698 | +$10.8M | 1.9% |
Showing the 10 largest of 129 changes.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SR Scholar Rock Hldg Corp | Trimmed | −796,350 | −$43.8M | 2.3% |
| Tango Therapeutics Inc | Added | +1,022,100 | +$32M | 6.6% |
| Syndax Pharmaceuticals Inc | Exited | −1,215,743 | −$28.4M | — |
| Erasca Inc | Added | +1,326,052 | +$24.3M | 4.9% |
| Revolution Medicines Inc | Trimmed | −121,689 | −$22.8M | 5.2% |
| Immunovant Inc | Trimmed | −469,967 | −$18.1M | 1.8% |
| Mbx Biosciences Inc | Exited | −499,469 | −$14.9M | — |
| Tyra Biosciences Inc | Added | +439,577 | +$14M | 3.5% |
| KP Kiniksa Pharmaceuticals Intl | New | +209,234 | +$13.4M | 2.3% |
| First Tracks Biotherapeutics | New | +622,723 | +$12.5M | 2.2% |
Showing the 10 largest of 115 changes.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Centessa Pharmaceuticals PLC | Exited | −1,154,114 | −$28.9M | — |
| Twist Bioscience Corp | Trimmed | −475,245 | −$22.6M | 0.4% |
| Arcellx Inc | Exited | −332,860 | −$21.7M | — |
| Revolution Medicines Inc | Added | +219,600 | +$21.4M | 5.3% |
| Terns Pharmaceuticals Inc | Exited | −429,198 | −$17.3M | — |
| Roivant Sciences Ltd | Trimmed | −580,898 | −$16.1M | 2.1% |
| Enliven Therapeutics Inc | New | +363,438 | +$14.2M | 2.8% |
| Cg Oncology Inc | New | +205,622 | +$13.9M | 2.7% |
| Biohaven Ltd | New | +1,594,491 | +$13.5M | 2.6% |
| Mbx Biosciences Inc | Added | +420,916 | +$12.6M | 2.9% |
Showing the 10 largest of 118 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Roivant Sciences Ltd | Trimmed | −3,230,489 | −$70.1M | 3.6% |
| AS Abivax Sa | Added | +225,510 | +$30.4M | 9.1% |
| Immunovant Inc | Trimmed | −944,621 | −$24M | 2.8% |
| Denali Therapeutics Inc | Trimmed | −1,315,601 | −$21.7M | 1.2% |
| Arcellx Inc | Added | +321,484 | +$21M | 3.7% |
| Twist Bioscience Corp | New | +518,355 | +$16.4M | 2.8% |
| Wave Life Sciences Ltd | Exited | −2,110,152 | −$15.4M | — |
| Structure Therapeutics Inc | Added | +221,738 | +$15.4M | 4.2% |
| Biohaven Ltd | Exited | −1,017,311 | −$15.3M | — |
| Cidara Therapeutics Inc | Exited | −152,325 | −$14.6M | — |
Showing the 10 largest of 119 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Roivant Sciences Ltd | Added | +3,595,406 | +$54.4M | 12.7% |
| Madrigal Pharmaceuticals Inc | Trimmed | −44,487 | −$20.4M | 0.8% |
| Mineralys Therapeutics Inc | Trimmed | −473,474 | −$18M | 1.2% |
| Arcellx Inc | Trimmed | −190,076 | −$15.6M | 0.2% |
| Syndax Pharmaceuticals Inc | Trimmed | −1,006,429 | −$15.5M | 4.2% |
| Denali Therapeutics Inc | Added | +1,026,744 | +$14.9M | 5.0% |
| Centessa Pharmaceuticals PLC | Trimmed | −610,287 | −$14.8M | 3.2% |
| Merus N V | Exited | −266,094 | −$14M | — |
| Biohaven Ltd | Added | +842,557 | +$12.6M | 3.1% |
| Cidara Therapeutics Inc | Trimmed | −114,449 | −$11M | 2.9% |
Showing the 10 largest of 100 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Roivant Sciences Ltd | Trimmed | −1,977,079 | −$22.3M | 2.2% |
| Cidara Therapeutics Inc | New | +266,774 | +$13M | 4.2% |
| Revolution Medicines Inc | Exited | −318,782 | −$11.3M | — |
| Nuvalent Inc | Trimmed | −130,573 | −$9.96M | 1.5% |
| Legend Biotech Corp | New | +270,144 | +$9.59M | 3.1% |
| Xenon Pharmaceuticals Inc | Exited | −274,633 | −$9.21M | — |
| Rhythm Pharmaceuticals Inc | Added | +142,936 | +$9.03M | 3.6% |
| Centessa Pharmaceuticals PLC | Added | +672,337 | +$8.83M | 5.3% |
| Mineralys Therapeutics Inc | New | +631,586 | +$8.55M | 2.7% |
| Geron Corp | Added | +5,688,937 | +$8.02M | 3.0% |
Showing the 10 largest of 81 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Arcellx Inc | New | +273,774 | +$18M | 5.7% |
| CP Crinetics Pharmaceuticals In | Exited | −317,060 | −$16.2M | — |
| Syndax Pharmaceuticals Inc | Trimmed | −1,274,007 | −$15.7M | 6.3% |
| Madrigal Pharmaceuticals Inc | New | +40,936 | +$13.6M | 4.3% |
| Incyte Corp | Exited | −193,623 | −$13.4M | — |
| SR Scholar Rock Hldg Corp | Added | +399,905 | +$12.9M | 5.8% |
| Merus N V | Trimmed | −268,056 | −$11.3M | 4.7% |
| PP Praxis Precision Medicines I | Exited | −134,178 | −$10.3M | — |
| Bristol-myers Squibb Co | Exited | −166,068 | −$9.39M | — |
| Rhythm Pharmaceuticals Inc | Trimmed | −174,200 | −$9.23M | 0.6% |
Showing the 10 largest of 84 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Trimmed | −1,277,352 | −$17.8M | 1.7% |
| Amicus Therapeutics Inc | Exited | −1,481,809 | −$15.8M | — |
| Syndax Pharmaceuticals Inc | Added | +1,141,410 | +$15.1M | 9.5% |
| Xenon Pharmaceuticals Inc | New | +375,845 | +$14.7M | 3.7% |
| Applied Therapeutics Inc | Exited | −1,554,586 | −$13.2M | — |
| Nuvalent Inc | New | +145,234 | +$11.4M | 2.8% |
| Immunovant Inc | Added | +447,507 | +$11.1M | 6.9% |
| Alkermes PLC | Added | +368,050 | +$10.6M | 3.0% |
| Autolus Therapeutics PLC | Exited | −2,616,602 | −$9.5M | — |
| Centessa Pharmaceuticals PLC | Added | +558,302 | +$9.35M | 2.7% |
Showing the 10 largest of 79 changes.
Loading...